Developer of pharmaceutical drugs. The company's pharmaceutical drugs development services enable businesses to engage in the full cycle of drug development -- from exploratory research, clinical development, manufacturing and marketing. Its pipeline includes drug therapies for prostate cancer, breast cancer, pediatric ependymoma, overactive bladder and rheumatoid arthritis. read more
Yoshihiko Hatanaka Astellas Pharma CEO Rating
Yoshihiko Hatanaka Astellas Pharma CEO Rating
Astellas Pharma's CEO, Yoshihiko Hatanaka, has 12 employee ratings and a score of 51/100, placing them in the Bottom 5% of similar size companies on Comparably with 10,000+ Employees.
Where This Score Ranks Astellas Pharma's CEO Rating
- BOTTOM5%
In the Bottom 5% of 1339 Similar Sized Companies on Comparably
- 3rd
3rd place versus 4 competitors rated on Comparably
40
Sep
48
Mar
51
Jun
49
Aug
54
Jan
F51 / 100
Jan
Astellas Pharma CEO Yoshihiko Hatanaka Bio
Yoshihiko Hatanaka serves as the CEO / President of Astellas Pharma.
Not Enough Ratings To Show Who Ranks CEO Rating the Highest
Anonymously rate my experience at Astellas PharmaNot Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at Astellas PharmaAstellas Pharma CEO Yoshihiko Hatanaka At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Astellas Pharma.
Based on 12 ratings, Yoshihiko Hatanaka ranks right below Takeda's CEO, Christophe Weber.
Overall, the CEO score has remained stable over the last 90 days.
Astellas Pharma CEO Yoshihiko Hatanaka Rating Trendline
- Astellas Pharma51
- Similar Size on Comparably
Astellas Pharma's CEO Rating Rank Against Similar Sized Companies on Comparably
BOTTOM
5%
Astellas Pharma ranks in the Bottom 5% of other companies on Comparably with 10,000+ Employees for CEO Rating Score.
Anonymously Ask Astellas Pharma Any Question
Are You an Employee at Astellas Pharma?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at Astellas Pharma
×